LFST
Income statement / Annual
Last year (2024), LifeStance Health Group, Inc.'s total revenue was $1.25 B,
an increase of 18.50% from the previous year.
In 2024, LifeStance Health Group, Inc.'s net income was -$57.44 M.
See LifeStance Health Group, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$1.25 B |
$1.06 B |
$859.54 M |
$667.51 M |
$377.22 M |
$212.52 M |
| Cost of Revenue |
$0.00
|
$753.57 M
|
$622.53 M
|
$466.00 M
|
$242.90 M
|
$150.12 M
|
| Gross Profit |
$1.25 B
|
$302.10 M
|
$237.02 M
|
$201.51 M
|
$134.32 M
|
$62.40 M
|
| Gross Profit Ratio |
1
|
0.29
|
0.28
|
0.3
|
0.36
|
0.29
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$363.06 M
|
$410.79 M
|
$377.99 M
|
$433.73 M
|
$69.65 M
|
$41.06 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$8.63 M
|
$1.94 M
|
$2.61 M
|
$646,000.00
|
| Selling, General & Administrative Expenses |
$363.06 M
|
$410.79 M
|
$377.99 M
|
$433.73 M
|
$330.74 M
|
$41.06 M
|
| Other Expenses |
$919.52 M
|
$80.44 M
|
$69.20 M
|
$54.14 M
|
$0.00
|
$6.10 M
|
| Operating Expenses |
$1.28 B
|
$491.23 M
|
$447.19 M
|
$487.86 M
|
$330.74 M
|
$47.16 M
|
| Cost And Expenses |
$1.28 B
|
$1.24 B
|
$1.07 B
|
$953.86 M
|
$361.78 M
|
$197.28 M
|
| Interest Income |
$0.00
|
$0.00
|
$19.93 M
|
$38.91 M
|
$22.13 M
|
$5.41 M
|
| Interest Expense |
$26.54 M
|
$21.22 M
|
$19.93 M
|
$38.91 M
|
$22.13 M
|
$5.41 M
|
| Depreciation & Amortization |
$70.95 M
|
$80.44 M
|
$69.20 M
|
$54.14 M
|
$31.05 M
|
$6.10 M
|
| EBITDA |
$39.87 M |
-$104.93 M |
-$136.41 M |
-$229.62 M |
$8.77 M |
$21.34 M |
| EBITDA Ratio |
0.03
|
-0.1
|
-0.16
|
-0.35
|
0.12
|
0.1
|
| Operating Income Ratio |
-0.03
|
-0.18
|
-0.24
|
-0.43
|
0.04
|
0.07
|
| Total Other Income/Expenses Net |
-$26.00 M
|
-$17.45 M
|
-$22.56 M
|
-$46.75 M
|
-$59.85 M
|
-$7.37 M
|
| Income Before Tax |
-$57.61 M
|
-$206.58 M
|
-$232.73 M
|
-$333.11 M
|
-$44.41 M
|
$7.88 M
|
| Income Before Tax Ratio |
-0.05
|
-0.2
|
-0.27
|
-0.5
|
-0.12
|
0.04
|
| Income Tax Expense |
-$170,000.00
|
-$20.32 M
|
-$17.17 M
|
-$25.91 M
|
-$6.34 M
|
$2.21 M
|
| Net Income |
-$57.44 M
|
-$186.26 M
|
-$215.56 M
|
-$307.20 M
|
-$38.07 M
|
$5.67 M
|
| Net Income Ratio |
-0.05
|
-0.18
|
-0.25
|
-0.46
|
-0.1
|
0.03
|
| EPS |
-0.15 |
-0.51 |
-0.61 |
-0.94 |
-0.1 |
0.0152 |
| EPS Diluted |
-0.15 |
-0.51 |
-0.61 |
-0.94 |
-0.1 |
0.0152 |
| Weighted Average Shares Out |
$379.15 M
|
$367.46 M
|
$355.28 M
|
$327.52 M
|
$373.65 M
|
$373.65 M
|
| Weighted Average Shares Out Diluted |
$379.15 M
|
$367.46 M
|
$355.28 M
|
$327.52 M
|
$373.65 M
|
$373.65 M
|
| Link |
|
|
|
|
|
|
